JAK2 c.2046_2047insGGTCCT ;(p.I682_R683insGP)

Variant ID: 9-5078359-C-CGGTCCT

NM_004972.3(JAK2):c.2046_2047insGGTCCT;(p.I682_R683insGP)

This variant was identified in 1 publication

View GRCh38 version.




Publications:


Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia.

Cancer Cell
Roberts, Kathryn G KG; Morin, Ryan D RD; Zhang, Jinghui J; Hirst, Martin M; Zhao, Yongjun Y; Su, Xiaoping X; Chen, Shann-Ching SC; Payne-Turner, Debbie D; Churchman, Michelle L ML; Harvey, Richard C RC; Chen, Xiang X; Kasap, Corynn C; Yan, Chunhua C; Becksfort, Jared J; Finney, Richard P RP; Teachey, David T DT; Maude, Shannon L SL; Tse, Kane K; Moore, Richard R; Jones, Steven S; Mungall, Karen K; Birol, Inanc I; Edmonson, Michael N MN; Hu, Ying Y; Buetow, Kenneth E KE; Chen, I-Ming IM; Carroll, William L WL; Wei, Lei L; Ma, Jing J; Kleppe, Maria M; Levine, Ross L RL; Garcia-Manero, Guillermo G; Larsen, Eric E; Shah, Neil P NP; Devidas, Meenakshi M; Reaman, Gregory G; Smith, Malcolm M; Paugh, Steven W SW; Evans, William E WE; Grupp, Stephan A SA; Jeha, Sima S; Pui, Ching-Hon CH; Gerhard, Daniela S DS; Downing, James R JR; Willman, Cheryl L CL; Loh, Mignon M; Hunger, Stephen P SP; Marra, Marco A MA; Mullighan, Charles G CG
Publication Date: 2012-08-14

Variant appearance in text: JAK2: Ile682_Arg683insGlyPro
PubMed Link: 22897847
Variant Present in the following documents:
  • Main text
View BVdb publication page